Autonomix Medical, Inc. (AMIX)
NASDAQ: AMIX · Real-Time Price · USD
4.830
-0.490 (-9.21%)
At close: Aug 31, 2026, 4:00 PM EDT
4.660
-0.170 (-3.52%)
After-hours: Aug 31, 2026, 7:57 PM EDT

Autonomix Medical Income Statement

Millions USD. Fiscal year is Apr - Mar.
Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Selling, General & Admin
9.329.896.865.251.2513.59
Research & Development
7.077.144.732.230.750
Operating Expenses
16.3817.0311.597.471.9913.59
Operating Income
-16.38-17.03-11.59-7.47-1.99-13.59
Interest Expense
---0.18-0.08--0.22
Interest & Investment Income
0.280.320.350.13--
Other Non Operating Income (Expenses)
----8-0.31
EBT Excluding Unusual Items
-16.11-16.72-11.41-15.43-1.99-13.5
Other Unusual Items
-----0.17
Pretax Income
-16.11-16.72-11.41-15.43-1.99-13.33
Net Income
-16.11-16.72-11.41-15.43-1.99-13.33
Preferred Dividends & Other Adjustments
------0.49
Net Income to Common
-16.11-16.72-11.41-15.43-1.99-12.84
Net Income Growth
------
Shares Outstanding (Basic)
00000-
Shares Outstanding (Diluted)
00000-
Shares Change
316.60%308.55%69.73%73.12%--
EPS (Basic)
-36.37-48.64-135.65-311.27-69.52-
EPS (Diluted)
-36.37-48.64-135.65-311.27-69.52-
EPS Growth
------

Additional Metrics

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Free Cash Flow
-13.23-12.29-8.27-6.67-1.85-0.39
Free Cash Flow Per Share
-29.88-35.77-98.34-134.53-64.77-
EBITDA
-16.37-17.02-11.41-7.39--
D&A For EBITDA
0.010.010.180.08--
EBIT
-16.38-17.03-11.59-7.47-1.99-13.59
Advertising Expenses
---1.8--
SEC Filings: 10-K · 10-Q